Track topics on Twitter Track topics that are important to you
Here are the most relevant search results for "Placebo Hepatitis Virus Infection" found in our extensive news archives from over 250 global news sources.
In addition to our news stories we have dozens of PubMed Articles about Placebo Hepatitis Virus Infection for you to read. Along with our medical data and news we also list Placebo Hepatitis Virus Infection Clinical Trials, which are updated daily. BioPortfolio also has a large database of Placebo Hepatitis Virus Infection Companies for you to search.
Scientists in the Center for Infection and Immunity at Columbia University’s Mailman School of Public Health have discovered a new virus in seals that is the closest known relative of the human hepatitis A virus. The finding provides new clues on the emergence of hepatitis A. The research appears in the July/August issue of mBio, the online open-access journal of the American Society for Microbi...
Hepatitis B virus (HBV) is a global health problem that can lead to cirrhosis and hepatocellular carcinoma (HCC). Although HBV vaccination has reduced the prevalence Of HBV infection, the burden of...
(American Society for Microbiology) Scientists in the Center for Infection and Immunity at the Mailman School of Public Health have discovered a new virus in seals that is the closest known relative of the human hepatitis A virus. The finding provide...
Worldwide, 185 million people have chronic hepatitis C. Since the late 1980s, when scientists discovered the virus that causes the infection, they have struggled to find ways to grow it in human cells in the lab -- an essential part of learning how the virus works and developing new effective treatments. In a study published in Nature on August
Treatment of hepatitis C virus (HCV) infection in patients with chronic kidney disease (CKD) can be challenging. Now, data from the phase III C-SURFER study show that grazoprevir and elbasvir — a new all-oral combination therapy for HCV — is safe...
University of Adelaide researchers have uncovered the role played by a family of genes, which can suppress hepatitis C virus (HCV) infection within the liver. The findings, published in the Journal of Biological Chemistry, shed light on the activity of these genes and how they produce a natural immune response to the virus. HCV is a major health
PALO ALTO, Calif., July 20, 2015 /PRNewswire/ -- Eiger BioPharmaceuticals Incorporated announced today the publication of results of the first Phase 2a study of lonafarnib in patients with chronic hepatitis delta virus (HDV) infection. The study was conducted at the National Institutes of Health (NIH) Clinical Center in Bethesda, Maryland. The double-blinded, randomized, placebo-contro...
(Reuters) - The U.S. Food and Drug Administration approved AbbVie Inc's treatment that targets hepatitis C virus with the rarest genotype, or genetic makeup. About 2.7 million Americans are infected with hep C virus, of which genotype 4 is among the ...
This slide show summarizes healthcare-associated outbreaks of hepatitis B virus (HBV) and hepatitis C virus (HCV) infection in the United States during 2008-2014, as reported to the CDC.
The UK's National Institute for Health and Care Excellence (NICE) has recommended Bristol-Myers Squibb's (BMS) daklinza (daclatasvir) to treat adults with chronic hepatitis C virus (HCV) infection in England and Wales.
Scientists have discovered a new virus that can be transmitted through the blood supply. Currently, it is unclear whether the virus is harmful or not, but it is related to hepatitis C virus (HCV) and human pegivirus (HPgV), the latter of which was fo...
(Johns Hopkins Medicine) People infected with the hepatitis C virus are at risk for liver damage, but the results of a new Johns Hopkins study now show the infection may also spell heart trouble.
UC Irvine Health researchers have developed a cost-effective one-step test that screens, detects and confirms hepatitis C virus (HCV) infections. Dr. Ke-Qin Hu, director of hepatology services, will present findings at the Annual Meeting of Ame...
In this Review, Lemon and colleagues describe the interactions of the RNA genome of hepatitis C virus with various host proteins and microRNAs. They discuss how these interactions affect viral RNA synthesis and decay, and how they influence the long-...
IFN-free regimens with direct-acting antivirals have quickly become the mainstay of treatment for HCV infection. Read more about them here. Current Opinion in Infectious Diseases
UC Irvine Health researchers have developed a cost-effective one-step test that screens, detects and confirms hepatitis C virus (HCV) infections. Dr. Ke-Qin Hu, director of hepatology services, will present findings at the Annual Meeting of American ...
(HealthDay)—The prevalence of chronic hepatitis B virus (HBV) infection has remained constant since 1999, according to a study published online Aug. 6 in Hepatology.
FRIDAY, Aug. 7, 2015 -- New research reveals high rates of hepatitis C infection among intravenous drug users and baby boomers seen in urban emergency departments. And three-quarters of those who tested positive for the potentially deadly virus did.....
On World Hepatitis Day (28 July) WHO highlights the urgent need for countries to enhance action to prevent viral hepatitis infection and to ensure that people who have been infected are diagnosed and offered treatment. This year, the Organization is focusing particularly on hepatitis B and C, which together cause approximately 80% of all liver cancer deaths and kill close to 1.4 million people e...
The Hepatitis C virus (HCV) infection is a chronic blood-borne viral infection that affects an estimated 160 million people worldwide. Alarmingly, chronic HCV infection accounts for one-quarter of the cases of cirrhosis and hepatocellular carcinoma (...
Upwards of a million more people have been infected with the hepatitis C virus (HCV) than current estimates indicate, according to new research from Weill Cornell Medicine. The investigators say their finding exposes a critical flaw in the survey that calculates disease prevalence and underscores the need for stronger public health policies to combat the viral infection.
Lonafarnib, a novel oral treatment for chronic hepatitis D virus (HDV) infection, reduces viral replication and is safe and well tolerated, according to an early trial. Reuters Health Information
The hepatitis A virus can trigger acute liver inflammation which generally has a mild course in small children but which can become dangerous in adults. The virus, which is found worldwide, has previously been considered to be a purely human pathogen...
The hepatitis A virus can trigger acute liver inflammation which generally has a mild course in small children but which can become dangerous in adults. The virus, which is found worldwide, has previously been considered to be a purely human pathogen which at most is found in isolated cases in non-human primates. An international team of